<DOC>
	<DOCNO>NCT01558531</DOCNO>
	<brief_summary>The purpose study evaluate efficacy drug-eluting balloon angioplasty follow versus conventional balloon angioplasty superficial femoral artery popliteal artery re-stenosis .</brief_summary>
	<brief_title>Drug Eluting Balloon Peripheral Intervention In-Stent Restenosis</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>age &gt; 18 year intermittent claudication ( Fontane III IV ) angiographic stenosis &gt; 50 % occlusion superficial femoralpopliteal artery &gt; 40mm , previously treat nitinol stent implantation , least one belowknee vessel ankle allergy Paclitaxel contraindication combine antiplatelet treatment life expectancy &lt; 1 year hypersensitivity contraindication one study drug lack consent need amputation angiographic evidence stent fracture</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>peripheral arterial disease</keyword>
	<keyword>drug-eluting balloon</keyword>
	<keyword>restenosis</keyword>
</DOC>